Legalization Research and Development Safety Treatment 
MMJ Recs
JANUARY 2, 2024
In recent years, the landscape of cancer treatment has witnessed a paradigm shift with the emergence of medical cannabis as a potential therapeutic ally. Today we’re here to explore the evolving relationship between medical cannabis and cancer treatment, shedding light on everything potential MMJ patients need to know.
Veriheal
FEBRUARY 14, 2024
In a recent hearing, the Arizona Senate Health and Human Services Committee unanimously approved a bill that would legalize therapeutic psilocybin centers for medically supervised use. This will also include licensing for centers that are working on psilocybin and psychedelic research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Chronicles
MAY 22, 2019
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. The Puyallup tribe has staked several claims in the state’s legal marijuana industry, opening two recreational stores in the Tacoma area.
Veriheal
FEBRUARY 28, 2022
The need for effective treatment is not only important for restoring one’s health but also for returning functioning and quality of life. Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A New Kind of Depression Treatment. Increasing Options for Depression Patients.
Cannabis Law Report
FEBRUARY 28, 2022
In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.
Veriheal
NOVEMBER 30, 2021
Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. In 2008, he published psychedelic safety guidelines.
The Cannigma
JULY 1, 2022
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Expert insights. Personalized for you.
98 
Let's personalize your content